CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Get valuable wealth management tips for 2023 to help you grow and protect your assets. Elevate your financial game today!
18,755 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Bed Bath & Beyond has agreed to acquire Fathom Holdings in an all-stock deal valued at about $53.38 million, a move t...
An Oppenheimer analyst has floated a $10 trillion valuation for SpaceX within five years, anchored by Starlink's cash...
Vanguard’s International High Dividend Yield ETF has raised payouts in 2025 and 2026, but the durability of its forei...
A 68-year-old investor locks in Social Security and tax moves as markets wobble. The hardest retirement money decisio...
Memory stocks look risky on the surface, yet the fundamentals are unusually strong. This article decodes what history...
A fresh wave of buying interest in XRP, Solana, and Shiba Inu hits the market as traders watch key resistance levels ...
Dreaming of a $5,251 monthly Social Security check? This guide unpacks the exact earnings and timing needed, plus pra...
Bitcoin, Ethereum and XRP anchor a choppy session as policymakers weigh new rules and traders parse liquidity and ris...
The FCC has approved the Nexstar-Tegna deal, creating a national local television powerhouse with 265 stations across...
The latest weekly data show the number people getting unemployment dropping to a 2½-year low, as initial claims ease ...
In 2026, thousands of retirees are receiving one-time social security back payments that could total up to $50,000, a...